Grant: $431,961 - National Institutes of Health - Jul. 16, 2009
No votes have been cast for this award yet
Award Description: Our overarching goals are to design better therapies for the treatment of brain tumors. Medulloblastoma, a pediatric malignancy of the cerebellum with the highest incidence of all pediatric brain tumors, and glioma, the most malignant and invasive adult brain tumor, have no optimal therapies. New molecular targets and approaches for clinical intervention are thus desperately needed to increase the survival rate and reduce side effects. The Shh signaling pathway is activated in both types of brain cancer and is required for tumor growth, constituting an excellent target for therapy.
Project Description: As defined in the Award Description Field
Jobs Summary: This project has 0 jobs created and 1 jobs retained among the positions are SUMMER RESEARCH, POST-DOCT. RESEARCHER. (Total jobs reported: 1)
Project Status: Less Than 50% Completed
This award's data was last updated on Jul. 16, 2009. Help expand these official descriptions using the wiki below.
Funds from this award have been disbursed to sub-grantees. Click here to see a list of sub-grantees.
|WISTAR INSTITUTE OF ANATOMY & BIOLOGY||$173,572||PHILADELPHIA||PA|